Bioavailability of ivermectin administered orally to dogs.
The bioavailability of three formulations of ivermectin was determined following oral administration to dogs. The average peak plasma level (Cmax) of ivermectin administered in the standard tablet formulation at 6 and 100 micrograms/kg of body weight was 2.97 and 44.31 ng/g, respectively. This suggest dose-dependent pharmacokinetics. Cmax and total ivermectin bioavailability, as assessed from the area under the plasma curve (AUC), were similar between two tablet formulations of ivermectin administered at 100 micrograms/kg. Furthermore, Cmax was similar following administration of radiolabelled ivermectin at 6 micrograms/kg in either a beef-based chewable formulation or in the standard tablet formulation.
Daurio
C P
CP
Merck Sharp and Dohme Research Laboratories, Rahway, NJ 07065.
Cheung
E N
EN
Jeffcoat
A R
AR
Skelly
B J
BJ
D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D004285:Dogs / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005260:Female; D007559:Ivermectin / Q000008:administration & dosage / Q000493:pharmacokinetics*
D007559:Ivermectin